Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Progestins | 4 | 2023 | 302 | 2.340 |
Why?
|
| Asthma | 12 | 2024 | 6172 | 1.480 |
Why?
|
| Drug Hypersensitivity | 5 | 2022 | 915 | 1.240 |
Why?
|
| Hypersensitivity | 3 | 2022 | 1155 | 1.120 |
Why?
|
| Gender Identity | 5 | 2024 | 757 | 1.000 |
Why?
|
| Anaphylaxis | 2 | 2023 | 755 | 0.910 |
Why?
|
| Desensitization, Immunologic | 5 | 2023 | 534 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 12076 | 0.760 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2023 | 200 | 0.700 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2022 | 345 | 0.680 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 311 | 0.660 |
Why?
|
| Progesterone | 2 | 2023 | 742 | 0.630 |
Why?
|
| beta-Lactams | 1 | 2019 | 157 | 0.580 |
Why?
|
| Dermatitis | 1 | 2018 | 200 | 0.550 |
Why?
|
| Transsexualism | 1 | 2019 | 206 | 0.520 |
Why?
|
| Homebound Persons | 2 | 2011 | 49 | 0.470 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 3217 | 0.460 |
Why?
|
| Electronic Health Records | 10 | 2024 | 4761 | 0.420 |
Why?
|
| Allergens | 1 | 2019 | 1402 | 0.380 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 1274 | 0.340 |
Why?
|
| Hypoglycemic Agents | 4 | 2023 | 3069 | 0.320 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1894 | 0.310 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 1452 | 0.290 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2244 | 0.270 |
Why?
|
| Receptors, Thromboxane | 1 | 2023 | 30 | 0.230 |
Why?
|
| Unified Medical Language System | 1 | 2024 | 89 | 0.230 |
Why?
|
| Urban Population | 1 | 2011 | 2023 | 0.220 |
Why?
|
| Bronchial Spasm | 1 | 2022 | 71 | 0.210 |
Why?
|
| Blood Glucose | 1 | 2017 | 6347 | 0.200 |
Why?
|
| Humans | 38 | 2024 | 758381 | 0.200 |
Why?
|
| Receptors, Neuropeptide | 1 | 2022 | 105 | 0.200 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 219 | 0.200 |
Why?
|
| Cell Degranulation | 1 | 2022 | 276 | 0.200 |
Why?
|
| Electronic Mail | 1 | 2023 | 213 | 0.190 |
Why?
|
| Obesity | 1 | 2023 | 12870 | 0.190 |
Why?
|
| Platelet Activation | 1 | 2023 | 645 | 0.170 |
Why?
|
| Menstrual Cycle | 1 | 2023 | 536 | 0.170 |
Why?
|
| Cetirizine | 1 | 2019 | 7 | 0.170 |
Why?
|
| Famotidine | 1 | 2019 | 17 | 0.160 |
Why?
|
| Demography | 1 | 2024 | 1651 | 0.160 |
Why?
|
| Length of Stay | 2 | 2011 | 6439 | 0.160 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2021 | 362 | 0.160 |
Why?
|
| Mastocytosis | 1 | 2021 | 149 | 0.160 |
Why?
|
| Skin Tests | 1 | 2020 | 637 | 0.150 |
Why?
|
| Mast Cells | 2 | 2022 | 1390 | 0.150 |
Why?
|
| Sulfides | 1 | 2019 | 170 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2022 | 950 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2023 | 565 | 0.150 |
Why?
|
| Spirometry | 1 | 2021 | 923 | 0.150 |
Why?
|
| Cyclopropanes | 1 | 2019 | 431 | 0.150 |
Why?
|
| Acetates | 1 | 2019 | 321 | 0.150 |
Why?
|
| Retrospective Studies | 7 | 2024 | 80170 | 0.140 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 782 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 290 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1245 | 0.120 |
Why?
|
| Female | 15 | 2024 | 390316 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 5403 | 0.110 |
Why?
|
| Contraception | 1 | 2017 | 349 | 0.110 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 1172 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 642 | 0.110 |
Why?
|
| Quinolines | 1 | 2019 | 759 | 0.110 |
Why?
|
| Weight Loss | 1 | 2023 | 2671 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1090 | 0.100 |
Why?
|
| Life Style | 1 | 2023 | 3886 | 0.100 |
Why?
|
| Aspirin | 1 | 2023 | 3132 | 0.100 |
Why?
|
| Comorbidity | 2 | 2023 | 10495 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2019 | 981 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2023 | 13447 | 0.090 |
Why?
|
| Bone Density | 2 | 2014 | 3533 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2017 | 1345 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2023 | 54136 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2024 | 4653 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 1230 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2019 | 2297 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4406 | 0.080 |
Why?
|
| Fertilization in Vitro | 1 | 2017 | 1292 | 0.080 |
Why?
|
| Serotonin | 1 | 2014 | 1040 | 0.080 |
Why?
|
| Male | 11 | 2024 | 358742 | 0.070 |
Why?
|
| Nurse Practitioners | 1 | 2011 | 268 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 2374 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2551 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 3018 | 0.070 |
Why?
|
| Waiting Lists | 1 | 2011 | 762 | 0.070 |
Why?
|
| Adult | 7 | 2024 | 219916 | 0.070 |
Why?
|
| Middle Aged | 8 | 2024 | 219560 | 0.070 |
Why?
|
| Homeostasis | 1 | 2017 | 3302 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3671 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58681 | 0.060 |
Why?
|
| Risk Factors | 3 | 2021 | 73806 | 0.060 |
Why?
|
| Disease Progression | 1 | 2021 | 13468 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10719 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2024 | 26182 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 1067 | 0.060 |
Why?
|
| Aged | 6 | 2021 | 168217 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5818 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 22031 | 0.050 |
Why?
|
| Hospitalization | 3 | 2022 | 10653 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8611 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7377 | 0.040 |
Why?
|
| Mutation | 2 | 2014 | 29915 | 0.040 |
Why?
|
| Cough | 1 | 2022 | 594 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2024 | 820 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2022 | 697 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8554 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 41252 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 29558 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 715 | 0.040 |
Why?
|
| Patients | 1 | 2023 | 904 | 0.030 |
Why?
|
| Mice | 1 | 2023 | 81107 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2023 | 1484 | 0.030 |
Why?
|
| Documentation | 1 | 2022 | 892 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15396 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2014 | 176 | 0.030 |
Why?
|
| United States | 1 | 2021 | 72140 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2021 | 1135 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2014 | 318 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 87888 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 167777 | 0.020 |
Why?
|
| Public Health | 1 | 2024 | 2658 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 58808 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 841 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2014 | 2608 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10112 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8823 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1651 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3732 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3801 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10505 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 2621 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2895 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18357 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15646 | 0.010 |
Why?
|
| Algorithms | 1 | 2023 | 13959 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15785 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 4485 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 12945 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2011 | 3433 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2011 | 3261 | 0.010 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_